Combined treatment with JAK inhibitors and excimer laser may be superior to treatment with tacrolimus and laser therapy in pediatric vitiligo.

Laser vision correction (LASIK and PRK) is a relatively new procedure used to reduce or eliminate a person's dependence on glasses and contact lenses. The procedure is performed on an outpatient basis ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A meta-analysis focused on excimer laser trabeculostomy ...

ROME – Ab interno excimer laser trabeculotomy is a promising option in the treatment of primary open-angle glaucoma, according a surgeon speaking here. “The procedure is fast and effective, and ...

STRATA Skin Sciences, Inc. SSKN recently highlighted findings from a newly published meta-analysis that reinforces the clinical efficacy of its core 308 nm excimer laser technology in treating plaque ...

April 20, 2004 — Low-dose excimer laser is effective for the treatment of oral lichen planus (OLP), according to the results of a single-center, before-after trial published in the April 18 issue of ...

OYAMA, Japan, December 08, 2025--(BUSINESS WIRE)--Gigaphoton Inc. (Head Office: Oyama, Tochigi; President and CEO: Tatsuo Enami), a manufacturer of lightsources for semiconductor lithography, ...

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company’s ...

The Excimer and Femtosecond Ophthalmic Lasers Market represents a transformative segment in the field of ophthalmology, offering advanced and precise solutions for various vision correction procedures ...

West Des Moines, Iowa - April 22, 2026 - PRESSADVANTAGE - Modern Vision Centers, a LASIK surgeon located in West Des ...

Gigaphoton, the Japanese company that provides excimer lasers for semiconductor lithography applications, says it will double production capacity of the light sources by 2023. The decision comes in ...